Lina Lundström
Research Subjects
Lina Lundström has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Christian Rück
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm, Sweden
2 shared publications - Oskar Flygare
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Christine Rummel-Kluge
Department of Psychiatry and Psychotherapy, Medical Faculty, Leipzig University, Leipzig, Germany
1 shared publication - David Mataix-Cols
Karolinska Institutet
1 shared publication - Elisabeth Kohls
Department of Psychiatry and Psychotherapy, Medical Faculty, Leipzig University, Leipzig, Germany
1 shared publication - Erik Andersson
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 13 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Acceptability, feasibility, and effectiveness of Internet-based cognitive behaviour therapy for obsessive-compulsive disorder (OCD-NET): Naturalistic pilot trial during the COVID-19 pandemic in a psychiatric outpatient department in Germany (Preprint)
UNSTRUCTURED Background: Cognitive behavior therapy (CBT) for obsessive-compulsive disorder (OCD) is the gold-standard treatment for OCD. However, access to CBT and specialized treatments is often limited. This pilot study describes the implementation of a guided Internet-based CBT program (ICBT) for individuals seeking treatment for OCD in a psychiatric outpatient department in Leipzig, Germany during the COVID-19 pandemic. The aim of the study was to investigate the acceptability, feasibility, and effectiveness of the ICBT program for OCD. Methods: In an open, naturalistic pilot trial, N = 57 patients with OCD received a 10-week ICBT program (called “OCD-NET”) consisting of 10 different modules of psychoeducation, cognitive restructuring, exposure with response prevention and overall therapist support and guidance via the program. The primary outcome was OCD symptoms at the end of treatment, assessed with the self-report Obsessive Compulsive Inventory – Revised (OCI-R). Secondary outcomes were self-rated measures of depressive symptoms, quality of life, self-efficacy, and psychological distress. Further, treatment credibility, working alliance, and satisfaction were assessed. Results: Mixed effect models showed a significant reduction in OCD symptoms (OCI-R) with large within-group effect sizes in both intention to treat (ITT) and completer analyses. In ITT analyses, the OCI-R decreased from 26.10 at baseline to 20.67 at post-treatment (mean reduction −5.43 points). On average, participants completed 6.30 (SD = 3.21) modules, and n = 19 (33.9%) participants completed all 10 modules of the program. Overall, n = 45 (78.9%) were treatment completers (minimum 4 modules completed), n = 11 (19.3%) were non-completers, and n = 1 (1.8%) was a dropout. At post-treatment, n = 17 (29.8%) participants showed a treatment response on the OCI-R (≥ 40% reduction). The treatment also resulted in statistically significant improvements in depressive symptoms and self-efficacy. Satisfaction with the program was high, with a majority of participants indicating that they would recommend it to others (n = 56, 98.2%) and that it provided the support they needed (n = 49, 86.0%). Conclusions: ICBT with therapist guidance reduces OCD symptoms and depressive symptoms meaningfully in real world settings. The OCD-NET program is overall highly acceptable and seem to fit patients’ needs in routine care, even under pandemic constraints. Results also indicate that this ICBT program fits to be blended into routine psychiatric outpatient treatments. However, future research may wish to investigate how upscaling and sustainable implementation could be reached effectively. Trial Registration: German Clinical Trials register: DRKS00021706
- 13 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAcceptability, feasibility, and effectiveness of Internet-based cognitive behaviour therapy for obsessive-compulsive disorder (OCD-NET): Naturalistic pilot trial during the COVID-19 pandemic in a psychiatric outpatient department in Germany (Preprint)
UNSTRUCTURED Background: Cognitive behavior therapy (CBT) for obsessive-compulsive disorder (OCD) is the gold-standard treatment for OCD. However, access to CBT and specialized treatments is often limited. This pilot study describes the implementation of a guided Internet-based CBT program (ICBT) for individuals seeking treatment for OCD in a psychiatric outpatient department in Leipzig, Germany during the COVID-19 pandemic. The aim of the study was to investigate the acceptability, feasibility, and effectiveness of the ICBT program for OCD. Methods: In an open, naturalistic pilot trial, N = 57 patients with OCD received a 10-week ICBT program (called “OCD-NET”) consisting of 10 different modules of psychoeducation, cognitive restructuring, exposure with response prevention and overall therapist support and guidance via the program. The primary outcome was OCD symptoms at the end of treatment, assessed with the self-report Obsessive Compulsive Inventory – Revised (OCI-R). Secondary outcomes were self-rated measures of depressive symptoms, quality of life, self-efficacy, and psychological distress. Further, treatment credibility, working alliance, and satisfaction were assessed. Results: Mixed effect models showed a significant reduction in OCD symptoms (OCI-R) with large within-group effect sizes in both intention to treat (ITT) and completer analyses. In ITT analyses, the OCI-R decreased from 26.10 at baseline to 20.67 at post-treatment (mean reduction −5.43 points). On average, participants completed 6.30 (SD = 3.21) modules, and n = 19 (33.9%) participants completed all 10 modules of the program. Overall, n = 45 (78.9%) were treatment completers (minimum 4 modules completed), n = 11 (19.3%) were non-completers, and n = 1 (1.8%) was a dropout. At post-treatment, n = 17 (29.8%) participants showed a treatment response on the OCI-R (≥ 40% reduction). The treatment also resulted in statistically significant improvements in depressive symptoms and self-efficacy. Satisfaction with the program was high, with a majority of participants indicating that they would recommend it to others (n = 56, 98.2%) and that it provided the support they needed (n = 49, 86.0%). Conclusions: ICBT with therapist guidance reduces OCD symptoms and depressive symptoms meaningfully in real world settings. The OCD-NET program is overall highly acceptable and seem to fit patients’ needs in routine care, even under pandemic constraints. Results also indicate that this ICBT program fits to be blended into routine psychiatric outpatient treatments. However, future research may wish to investigate how upscaling and sustainable implementation could be reached effectively. Trial Registration: German Clinical Trials register: DRKS00021706
- Open Access
- 28 March 2022
- Published by Center for Open Science in PsyArXiv
Empirically defining treatment response and remission in obsessive-compulsive disorder using the Obsessive-Compulsive Inventory-Revised
In clinical trials of obsessive-compulsive disorder (OCD), clinical outcomes are generally measured using lengthy clinician-administered interviews. However, in routine clinical practice, many clinicians lack the time to administer such instruments. This study evaluated cut-offs for treatment response and remission in OCD using the self-rated Obsessive-Compulsive Inventory-Revised (OCI-R). Data from 349 patients in three clinical trials of cognitive behavior therapy for OCD were pooled for analysis. The OCI-R was compared to gold-standard criteria for response and remission based on the clinician-administered Yale-Brown Obsessive Compulsive Scale and the Clinical Global Impression Scale. The results showed that a ≥40% reduction on the OCI-R was the optimal cut-off for treatment response, with a sensitivity of 0.72 and a specificity of 0.79. For remission status, the optimal cut-off was ≤8 points on the OCI-R, with a sensitivity of 0.57 and specificity of 0.83. These cut-offs provide a simple and time-efficient way to determine treatment response and remission in OCD when the administration of clinician-administered instruments is unfeasible.
- 28 March 2022
- Published by Center for Open Science in PsyArXiv
Open AccessEmpirically defining treatment response and remission in obsessive-compulsive disorder using the Obsessive-Compulsive Inventory-Revised
In clinical trials of obsessive-compulsive disorder (OCD), clinical outcomes are generally measured using lengthy clinician-administered interviews. However, in routine clinical practice, many clinicians lack the time to administer such instruments. This study evaluated cut-offs for treatment response and remission in OCD using the self-rated Obsessive-Compulsive Inventory-Revised (OCI-R). Data from 349 patients in three clinical trials of cognitive behavior therapy for OCD were pooled for analysis. The OCI-R was compared to gold-standard criteria for response and remission based on the clinician-administered Yale-Brown Obsessive Compulsive Scale and the Clinical Global Impression Scale. The results showed that a ≥40% reduction on the OCI-R was the optimal cut-off for treatment response, with a sensitivity of 0.72 and a specificity of 0.79. For remission status, the optimal cut-off was ≤8 points on the OCI-R, with a sensitivity of 0.57 and specificity of 0.83. These cut-offs provide a simple and time-efficient way to determine treatment response and remission in OCD when the administration of clinician-administered instruments is unfeasible.